Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04202809 |
| Title | Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC. (ESPADURVA) |
| Acronym | ESPADURVA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University Hospital, Essen |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Klinikum rechts der Isar - Technische Universität München | RECRUITING | Munich | Bavaria | 81675 | Germany | Details |
| Universitätsklinikum Essen | RECRUITING | Essen | 45147 | Germany | Details | |
| Universitätsklinikum Freiburg | RECRUITING | Freiburg | 79106 | Germany | Details | |
| Lungenklinik Hemer Deutscher Gemeinschafts-Diakonieverband GmbH | RECRUITING | Hemer | 58675 | Germany | Details | |
| Pius-Hospital Oldenburg | RECRUITING | Oldenburg | 26121 | Germany | Details | |
| Universitätsklinikum Regensburg | RECRUITING | Regensburg | 93042 | Germany | Details | |
| Robert-Bosch-Krankenhaus | RECRUITING | Stuttgart | 70376 | Germany | Details |